Cardiac strain is lower among women with HIV in relation to monocyte activation

Mabel Toribio1, Magid Awadalla2, Zsofia D Drobni2

  • 1Division of Endocrinology, Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.

Plos One
|December 30, 2022
PubMed

Insights

Women with HIV (WWH) show reduced left ventricular systolic function, indicated by lower global longitudinal strain (GLS). Inflammatory monocyte activation is linked to this dysfunction, suggesting a potential therapeutic target for heart failure prevention.

Area of Science:

  • Cardiology
  • Immunology
  • Infectious Diseases

Background:

  • Women with HIV (WWH) have an increased risk of heart failure.
  • Understanding the immune and inflammatory pathways contributing to left ventricular (LV) systolic dysfunction in WWH is crucial but limited.

Purpose of the Study:

  • To investigate the relationship between global longitudinal strain (GLS), a measure of LV systolic function, and monocyte activation in WWH.
  • To explore potential immune pathways involved in cardiac dysfunction among WWH.

Main Methods:

  • Cardiovascular magnetic resonance imaging was used to assess GLS.
  • Flow cytometry was employed to measure monocyte activation.
  • The study included 20 WWH and 14 women without HIV.

Main Results:

  • WWH exhibited significantly lower GLS compared to women without HIV (19.4±3.0% vs. 23.1±1.9%, P<0.0001).
  • HIV status independently predicted lower GLS.
  • In WWH, lower GLS correlated with increased expression of HLA-DR on CD14+CD16+ monocytes and was predicted by inflammatory monocyte activation, even after adjusting for CD4+ T-cell count and viral load.

Conclusions:

  • Inflammatory monocyte activation is associated with reduced LV systolic function in WWH.
  • Further research is needed to confirm the role of inflammatory monocyte activation in the pathogenesis of lower GLS.
  • Targeting inflammatory pathways may offer a strategy to mitigate heart failure risks in WWH.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
65
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
24
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
43